Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?

Lauren C. Davis, Elizabeth Sapey, David R. Thickett, Aaron Scott

Source: Eur Respir Rev, 31 (163) 210121; 10.1183/16000617.0121-2021
Journal Issue: March

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lauren C. Davis, Elizabeth Sapey, David R. Thickett, Aaron Scott. Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?. Eur Respir Rev, 31 (163) 210121; 10.1183/16000617.0121-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patients’ perspectives on exposure to environmental contaminants: a missing piece in pulmonary rehabilitation?
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 2
Year: 2020


Biomarkers of inhalation - what’s new and what is useful in smoking cessation and reduction trials?
Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies
Year: 2003

Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke?
Source: Eur Respir J, 55 (4) 2000447; 10.1183/13993003.00447-2020
Year: 2020



Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
Year: 2020



Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020
Year: 2020



Late Breaking Abstract - Identifying and addressing patient beliefs driving SABA use and over-reliance
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019



Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?
Source: Breathe, 17 (1) 2000068; 10.1183/20734735.0275-2020
Year: 2021



When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021



Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?
Source: Eur Respir J 2004; 24: 1-2
Year: 2004


Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Year: 2021



The fog, the attractive and the addictive: pulmonary effects of vaping with a focus on the contribution of each major vaping liquid constituent
Source: Eur Respir Rev, 29 (157) 200268; 10.1183/16000617.0268-2020
Year: 2020



Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries
Source: ERJ Open Res, 5 (4) 00182-2019; 10.1183/23120541.00182-2019
Year: 2019



Immediate effects of smoking: does tobacco and electronic cigarettes differ?
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019


Assessment of efficacy of pulmonary rehabilitation: which outcomes do we need to focus on?
Source: ERS Course 2017
Year: 2017

Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Whither pulmonary rehabilitation? Will alternative modes help or hurt?
Source: Eur Respir J, 52 (4) 1801678; 10.1183/13993003.01678-2018
Year: 2018



Current clinical management of smoke inhalation injuries: a reality check
Source: Eur Respir J, 52 (6) 1802163; 10.1183/13993003.02163-2018
Year: 2018



Does short-term treatment intensification influence long-term treatment effects on health status in COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 293s
Year: 2005

Impact of pulmonary rehabilitation: can we identify good responders?
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004

Minimising the environmental impact of inhaled therapies
Source: Eur Respir J, 55 (5) 2000721; 10.1183/13993003.00721-2020
Year: 2020